MDR News from the EU: the CAMD

CAMD announces efforts to avoid plausible future shortage of essential medical devices On October 20-21, 2022, the 51st meeting of the European Union Competent Authorities for Medical Devices (CAMD) was held in Prague under the Czech Presidency of the Council of the European Union. As a reminder, with the adoption of the European Medical Device…

How to control blood sugar in individuals with diabetes?

Efficacy of ayurvedic preparations in improving glycemic control in subjects with type 2 diabetes Several medicinal plants are used in traditional Ayurvedic medicine in the management of type 2 diabetes mellitus, and some recent research has shown their efficacy and safety.  This recent systematic review evaluated and summarized the available efficacy and safety evidence on…

IQVIA: flu season boosts consumption

Pharmaceutical market boosts consumption thanks to flu season: +54% cough products The pharmacy market is back in the positive on the main push of influenza and airway viruses (rhinoviruses, adenoviruses), which continue to show a very strong growth curve compared to past years. This is the update coming from the report which Iqvia updates the…

The future of medical device regulation

In plenary in the European Parliament on the item “Review of the Medical Device Regulation” the future of the Medical Device Regulation was discussed. Recall that with the adoption of the European Medical Device Regulation (MDR) 2017/745, the regulation has changed dramatically. The main objective of the MDR is to “establish a robust, transparent, predictable…

Cardioprotective activity of Korean ginseng

Protective effects of Korean ginseng on myocardial ischemia-reperfusion damage Myocardial ischemia, also called ischemic heart disease, involves myocardial tissue and is due to the establishment of an imbalance between the blood supply here and the tissue’s demand for oxygen, which then becomes hypoxic. Korean ginseng (Panax ginseng C. A. Meyer) appears to be effective in…

Cannabidiol as novel food: EFSA suspends judgment

Safety evaluation of cannabidiol (CBD) in food supplement suspended Given the numerous questions regarding the use of cannabidiol (CBD) in foods and in particular in food supplements, EFSA has published the statement on the safety of cannabidiol (CBD), in which it states that its safety of use, as a novel food, cannot be demonstrated due…